Youxin Chen
Peking Union Medical College Hospital · Peking Union Medical College · Peking Union Medical College Hospital of Chinese Academy of Medical Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Youxin Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:05 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05940428 · A Study of ASKG712 in Patients With Diabetic Macular EdemaVisara, Inc. · completed · Diabetic Macular Edema · principal investigator
- Ph3NCT05885503 · Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular EdemaRemeGen Co., Ltd. · unknown · Diabetic Macular Edema · principal investigator
- N/ANCT05639660 · Clinical Implication of Aflibercept in PCV Treatment in ChinaPeking Union Medical College Hospital · unknown · Polypoidal Choroidal Vasculopathy · study chair
- Ph3NCT05461339 · TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular DegenerationBioDlink Biopharm Co., Ltd. · active not recruiting · Neovascular Age-related Macular Degeneration · principal investigator
- Ph3NCT05439629 · Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular DegenerationBio-Thera Solutions · completed · Neovascular (Wet) Age-related Macular Degeneration · principal investigator
- Ph3NCT05345236 · A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)Qilu Pharmaceutical Co., Ltd. · completed · Wet Age-related Macular Degeneration · principal investigator
- N/ANCT05229237 · Conbercept for Polypoidal Choroidal Vasculopathy(START Study)Peking Union Medical College Hospital · completed · Polypoidal Choroidal Vasculopathy, Conbercept · study chair
- Ph2NCT05141994 · Clinical Study on the Efficacy and Safety of BAT5906 InjectionBio-Thera Solutions · completed · Wet Age-related Macular Degeneration · principal investigator
- Ph2NCT04922151 · 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · unknown · Pathological Myopic Choroidal Neovascularization · principal investigator
- Ph1/Ph2NCT04772105 · Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular EdemaBio-Thera Solutions · completed · Diabetic Macular Edema · principal investigator
- Ph3NCT04572698 · A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration(wAMD)Luye Pharma Group Ltd. · unknown · Age Related Macular Degeneration · principal investigator
- Ph1NCT04222842 · CM082 in Patients With Myopic Choroidal Neovascularization (CNV)AnewPharma · suspended · Myopic Choroidal Neovascularisation · principal investigator
- Ph1NCT04151212 · A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular DegenerationBio-Thera Solutions · completed · Age-related Macular Degeneration · principal investigator
- Ph1NCT03675880 · TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) SubjectsLee's Pharmaceutical Limited · unknown · AMD · study director
- Ph4NCT02905409 · Study of Surgery in Patients With Idiopathic Macular HolePeking University People's Hospital · unknown · Idiopathic Macular Hole, Surgery · principal investigator
- Ph4NCT01574430 · Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)Peking University People's Hospital · completed · Central Serous Chorioretinopathy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:05 UTC. The ranking covers the 200 most relevant of 4910 PubMed records, and a shared surname and initials can bring in a namesake. All 4910 on PubMed
- 57 citationsRCR 9.5
- 53 citationsRCR 10.8
- Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial.Nat Med · 202538 citationsRCR 7.3
- 37 citationsRCR 8.0
- 30 citationsRCR 7.6
- Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.J Clin Oncol · 202628 citationsRCR 14.0
- 25 citationsRCR 4.6
- 24 citationsRCR 5.1
- 23 citationsRCR 5.7
- 19 citationsRCR 9.5